Stroke Diagram (Photo credit: ConstructionDealMkting) |
Brain stroke, broadly can be of two
types;
·
First is ischemic stroke due to
blockage of artery supplying blood to the brain by a clot, developing there,
called thrombosis, something similar to the heart stroke; or a clot lodged in brain from other parts of the body called embolism.
· Second is hemorrhagic stroke, due to
bleeding from artery.
A thrombus or embolism can be treated in two
ways, one by removal by devices; or second, some clot dissolving medications
can be delivered at the site of thrombosis through arterial route, or through
systemic intravenous therapy.
The warning symptoms of stroke are to
be known to public, so that the valuable post-stroke time can be optimally
utilized; which is 3-00 hours for best results; from 3.0 to 4.5 hours with good
results. After 4.5 hours, there may not be any benefit.
The patient of stroke may have
warning symptoms like;
- Sudden inability to use limb/limbs or feeling of weakness that increases gradually to a state of paralysis/paresis; which most commonly present in one side of body.
- Twisting of face to one side.
- Slurred speech or absent of speech.
- Sudden fall down from upright position.
- Sudden black out.
- Inability to close eyes completely, etc.
There is certain
guidelines/algorhythm to be followed to select the suitable patients for the
therapy. The most important among those is to establish that the stroke is not
due to intra-cranial/cerebral hemorrhage.
English: Intracerebral haemorrhage in alcoholic patient who presented with left hemiparesis and slurresd speech (Photo credit: Wikipedia) |
Thrombolysis is usually achieved by
the agent called tPA (Tissue Plasminogen Activator); the recombinant tissue plasminogen activators
(r-tPAs) include alteplase, reteplase, and tenecteplase (TNKase). Additional
r-tPAs, such as desmoteplase, are under clinical
development, derived from vampire bats.
The
therapy is given either intra-arterially at the thrombus or intravenously;
studies find no difference in the ultimate outcome of treatment as regards to any
particular route of administration of r-TPAs.
The
devices used for removal of clots from the blood vessels are Penumbra and Merci
Retriever. In penumbra the thrombus is sucked into the device; whereas, Merci Retriever
uses a spring like coiled end to drag the clot out.
FDA
approval for the Penumbra aspiration device was received by the company in
January 2008, when it was judged to be "substantially equivalent" to
another currently approved mechanical device, the Concentric Balloon Guide
Catheter (Concentric Medical Inc) for the indication of revascularization of
patients with acute ischemic stroke secondary to large vessel occlusive disease.
The name
MERCI is an acronym
for Mechanical Embolus Removal in Cerebral Ischemia;
designed by University
of California, Los Angeles in 2001. It was first device to be approved by
FDA in August 2004 for removal
of blood clots in acute ischemic stroke.
Sometimes, in selected cases, mostly
in a little late case, both mechanical device and r-TPA are used to get good results.
The crucial aspect of getting good
result from the above treatments is recognizing the symptoms of stroke and
arrival in a well equipped hospital within the prescribed time limit.